Graphico

Graphico EBITDA

Delisted

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Graphico (4930.T) as of Nov 14, 2026 is 289.23 M JPY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 237.14 M JPY — a change of 21.97% (higher).

EBITDA

289.23 MJPY

YoY

21.97%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Graphico is 2023 289.23 M JPY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Graphico was 2022 237.14 M JPY. It decreases by 21.97% higher compared to the previous year.

The Graphico EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2014
127.11 M JPY
Jan 1, 2015
186.03 M JPY
Jan 1, 2018
182.44 M JPY
Jan 1, 2019
217.96 M JPY
Jan 1, 2020
241.19 M JPY
Jan 1, 2021
325.67 M JPY
Jan 1, 2022
237.14 M JPY
Jan 1, 2023
289.23 M JPY
The Graphico EBITDA history
YEAREBITDAYoY
289.23 MJPY+21.97%
237.14 MJPY-27.19%
325.67 MJPY+35.03%
241.19 MJPY+10.66%
217.96 MJPY+19.47%
182.44 MJPY-1.93%
186.03 MJPY+46.36%
127.11 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Graphico Stock analysis

What does Graphico do? Graphico Inc. generates revenue through the sale of health foods, cosmetics, ethical drugs, over-the-counter drugs, and household products via drug stores, general merchandise stores, home centers, variety stores, and mail-order channels. The company outsources manufacturing and logistics while focusing on product planning, development, marketing, and sales. Its main product categories include healthcare centered on health foods, beauty care centered on cosmetics, and ethical and over-the-counter drugs. Overseas sales are handled through country-specific distributors. The company targets consumers seeking health and beauty solutions through established retail channels and direct mail-order services. Product planning and development are central to its strategy, with a focus on health foods, cosmetics, and pharmaceuticals. The firm operates as a fabless business model, relying on external partners for manufacturing and logistics to maintain agility in product innovation. Graphico Inc. serves multiple segments including health-conscious women, beauty care consumers, and individuals seeking over-the-counter medications. Sales channels include drug stores, GMS, home centers, variety stores, and mail-order systems. The company's overseas presence is supported by distributors in each country, enabling global market access without direct operational infrastructure. Graphico is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Graphico stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Graphico is 289.23 M JPY in 2023.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Graphico changed from 237.14 M JPY to 289.23 M JPY, representing a 21.97% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Graphico since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Graphico historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Graphico

All Key Metrics — Graphico